Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid

Zhonghui Tang1, Yinqi Bai2, Qi Fang3

  • 1Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.

Cancer Cell
|April 4, 2025
PubMed

Insights

Tertiary lymphoid structures (TLSs) in liver cancer can be immature. Targeting tryptophan metabolism promotes TLS maturation, enhancing anti-PD-1 immunotherapy and tumor control.

Area of Science:

  • Immunology
  • Oncology
  • Systems Biology

Background:

  • Tertiary lymphoid structures (TLSs) are immune cell aggregates in tumors, associated with better cancer outcomes and immunotherapy efficacy.
  • The developmental pathways and factors influencing TLS maturation remain incompletely understood, particularly in hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To comprehensively profile TLSs and their microenvironment across different maturation stages in HCC using spatial transcriptomics.
  • To identify distinct developmental trajectories of immature TLSs and their functional implications for immunotherapy.

Main Methods:

  • Near single-cell spatial transcriptomic mapping of TLSs and their surrounding microenvironment in HCC.
  • Classification of immature TLSs based on developmental trajectories into 'conforming' and 'deviating' subtypes.
  • In vivo experiments involving inhibition of tryptophan metabolism and combination with anti-PD-1 therapy.

Main Results:

  • Immature TLSs were classified into conforming and deviating types, with conforming TLSs exhibiting functional similarity to mature TLSs in supporting immunotherapy.
  • A tryptophan-enriched metabolic microenvironment, driven by malignant cells, was identified as a key factor promoting TLS maturation deviation.
  • Inhibition of tryptophan metabolism enhanced intratumoral TLS maturation, improved tumor control, and synergized with anti-PD-1 immunotherapy.

Conclusions:

  • Conforming TLSs are functionally relevant for immunotherapy responses, whereas deviating TLSs are not.
  • Modulating the tumor microenvironment, specifically by targeting tryptophan metabolism, can promote TLS maturation.
  • Enhancing TLS maturation presents a promising therapeutic strategy to improve antitumor immunity and clinical outcomes in HCC patients undergoing immunotherapy.